Global PLGA Market Size Study & Forecast, by Application, Formulation Type, Biodegradability, End Use and Regional Forecasts 2025-2035

The global PLGA (poly(lactic-co-glycolic acid)) market is valued at approximately USD 1.7 billion in 2024 and is projected to expand at a staggering CAGR of 14.21% over the forecast period 2025 to 2035. Widely acclaimed for its biodegradability and biocompatibility, PLGA has emerged as a cornerstone polymer in modern pharmaceutical and biomedical applications. It's the backbone of advanced drug delivery systems, precision tissue engineering scaffolds, and sustained-release implants. As research institutions and biotech companies continuously push the limits of controlled release formulations and regenerative therapies, PLGA's prominence is surging. The rising prevalence of chronic conditions, increasing demand for targeted therapeutics, and innovations in bioresorbable technologies continue to fuel the momentum of this polymer's global footprint.

A critical factor influencing this accelerated adoption is the exponential rise in demand for long-acting injectable drugs and site-specific drug delivery systems, particularly in oncology, infectious diseases, and chronic disorders. PLGA-based microspheres and nanoparticles offer unmatched advantages in enhancing therapeutic efficacy, reducing dosing frequency, and improving patient compliance. Moreover, the market is being further driven by regulatory approvals of PLGA-based formulations and the expanded use of these biodegradable polymers in diagnostic imaging and surgical implants. Simultaneously, the growing shift toward sustainable, bio-based materials within the healthcare and pharmaceutical sectors has strengthened the case for PLGA as a leading-edge solution. The introduction of hybrid composites and customized polymer designs is opening new avenues for precision medicine and multifunctional delivery platforms.

Regionally, North America holds a commanding position in the global PLGA market, underpinned by its robust pharmaceutical infrastructure, deep-rooted research ecosystem, and high healthcare expenditure. The United States, home to many pioneering biotech firms and regulatory-driven innovations, leads regional dominance. Meanwhile, Europe follows closely, driven by strong investments in biopharmaceutical R&D and growing adoption of advanced therapeutic platforms across Germany, France, and the UK. However, Asia Pacific is poised to be the fastest-growing region through 2035, fueled by expanding healthcare access, increasing clinical research activities, and surging demand for affordable and scalable drug delivery systems in countries like China, India, and South Korea. With rising government support and local manufacturing capabilities, the region is quickly evolving into a global hub for PLGA innovation and deployment.

Major market player included in this report are:

• BASF SE
• Evonik Industries AG
• Corbion N.V.
• Ashland Global Holdings Inc.
• Alkermes Plc
• Boehringer Ingelheim
• Sigma-Aldrich (Merck KGaA)
• Poly-Med Inc.
• Shenzhen Esun Industrial Co., Ltd.
• Akina, Inc.
• Surmodics, Inc.
• Synbra Technology B.V.
• Mitsubishi Chemical Holdings Corporation
• Durect Corporation
• NovaMatrix

Global PLGA Market Report Scope:

• Historical Data - 2023, 2024
• Base Year for Estimation - 2024
• Forecast period - 2025-2035
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope - Free report customization (equivalent up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players.

The detailed segments and sub-segments of the market are explained below:

By Application:

• Drug Delivery
• Surgical Implants
• Tissue Engineering
• Diagnostic Imaging

By Formulation Type:

• Microspheres
• Nanoparticles
• Films
• Hydrogels

By Biodegradability:

• Biodegradable
• Non-Biodegradable

By End Use:

• Pharmaceuticals
• Biotechnology
• Research Institutions

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Key Takeaways:

• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.